XBiotech Inc. Company Profile
NASDAQ: XBITHealthcareBiotechnologyUSD
At close: Oct 8, 4:00 PM ET · Delayed 15 min
XBiotech at a glance
XBiotech Inc. (NASDAQ: XBIT) is a Biotechnology company in the Healthcare sector headquartered in Austin, TX. XBiotech is led by Dr. Sushma Shivaswamy Ph.D. and employs about 87 people. The company's shares have traded publicly since 2015.
At a market capitalization of $66.8 million, it is considered a small-cap company. Its SEC Central Index Key (CIK) is 0001626878, which identifies the company's filings on EDGAR.
Summary generated from market data by MetaCap's automated system. Methodology
What does XBiotech do?
XBiotech Inc., a biopharmaceutical company, discovers, and develops, True Human monoclonal antibodies for treating various diseases. It develops a pipeline of product candidates targeting inflammatory and infectious diseases. The company is also developing interleukin-1 alpha therapies to various medical conditions, such as cancer, stroke, heart attack, or arthritis; and mediates tissue breakdown, angiogenesis, the formation of blood clots, malaise, muscle wasting, and general inflammation. The company was incorporated in 2005 and is headquartered in Austin, Texas.
Business description based on the company's public filings.
Company information
- Legal name
- XBiotech Inc.
- Ticker
- NASDAQ: XBIT
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Dr. Sushma Shivaswamy Ph.D.
- Employees
- 87
- Headquarters
- 5217 Winnebago Lane, Austin, TX, United States
- Phone
- 512 386 2900
- Website
- xbiotech.com
- IPO year
- 2015
- Market cap
- $66.77M
- SEC CIK
- 0001626878
Companies similar to XBiotech
| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| SPROSpero Therapeutics Inc. | 1.14 | -2.56% | $66.39M | vs XBIT |
| RNTXRein Therapeutics Inc. | 0.7693 | -2.46% | $66.37M | vs XBIT |
| HYFTMindWalk Holdings Corp. | 1.43 | -4.67% | $67.37M | vs XBIT |
| HRTXHeron Therapeutics Inc. | 0.3582 | -6.79% | $68.01M | vs XBIT |
| CSBRChampions Oncology Inc. | 4.98 | +2.05% | $69.31M | vs XBIT |
| TENXTenax Therapeutics Inc. | 1.86 | -2.62% | $69.61M | vs XBIT |
| FBIOFortress Biotech Inc. | 2.09 | +2.45% | $69.70M | vs XBIT |
| APLMApollomics Inc. Class A | 21.78 | +1.30% | $63.49M | vs XBIT |